An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial

S. Najjar, Samer; S. Slaughter, Mark; D. Pagani, Francis; C. Starling, Randall; C. McGee, Edwin; Eckman, Peter; Tatooles, Antone; Moazami, Nader; L. Kormos, Robert; R. Hathaway, David; B. Najarian, Kevin; Bhat, Geetha; D. Aaronson, Keith; W. Boyce, Steven

doi:10.1016/j.healun.2013.12.001

Public

An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial

Published in The Journal of Heart and Lung Transplantation • Dec 12, 2013

Authors:

Samer S. Najjar

Mark S. Slaughter

Francis D. Pagani

Abstract

BACKGROUND: The HeartWare left ventricular assist device (HVAD, HeartWare Inc, Framingham, MA) is the first implantable centrifugal continuous-flow pump approved for use as a bridge to transplantation. An infrequent but serious adverse event of LVAD support is thrombus ingestion or formation in the ...

Subject

Medicine

Thrombus

Ventricular assist device

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!